LEADER 03955nam 22006255 450 001 9910253896303321 005 20200630104511.0 010 $a94-007-7678-0 024 7 $a10.1007/978-94-007-7678-4 035 $a(CKB)3710000000873126 035 $a(DE-He213)978-94-007-7678-4 035 $a(MiAaPQ)EBC6312272 035 $a(MiAaPQ)EBC5585541 035 $a(Au-PeEL)EBL5585541 035 $a(OCoLC)1026456359 035 $a(PPN)19550867X 035 $a(EXLCZ)993710000000873126 100 $a20160901d2016 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aBiomarkers in Cardiovascular Disease /$fedited by Vinood B. Patel, Victor R. Preedy 205 $a1st ed. 2016. 210 1$aDordrecht :$cSpringer Netherlands :$cImprint: Springer,$d2016. 215 $a1 online resource (213 illus., 138 illus. in color. eReference.) 225 1 $aBiomarkers in Disease: Methods, Discoveries and Applications,$x2542-3657 311 $a94-007-7679-9 311 $a94-007-7677-2 327 $aHigh-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation -- Mass Spectrometry-Based Lipidomics for Biomarker Research -- Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation -- Pentraxin 3 as Biomarker -- Isoprostanes as Biomarkers of Disease and Early Biological Effect -- Fetal Membranes: Potential Source of Preterm Birth Biomarkers -- 1-Hydroxypyrene as a Biomarker for Environmental Health -- Biomarkers of Necrosis and Myocardial Remodeling -- Serum Heat Shock Proteins as Novel Biomarker for Heart -- Failure and Cardiovascular Diseases -- Traditional and Proteomic Biomarkers of Autosomal Dominant -- Polycystic Kidney Disease (ADPKD) -- Biomarker for Amyotrophic Lateral Sclerosis -- Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control -- Biomarkers of Graft-Versus-Host Disease. 330 $aOn an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide.  Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Cardiovascular Disease combines detailed information on different cardiovascular conditions and the concomitant application of conventional, new and emerging biomarkers. It covers the latest knowledge, trends and applications. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry. 410 0$aBiomarkers in Disease: Methods, Discoveries and Applications,$x2542-3657 606 $aCancer research 606 $aOncology   606 $aPharmacology 606 $aCancer Research$3https://scigraph.springernature.com/ontologies/product-market-codes/B11001 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aPharmacology/Toxicology$3https://scigraph.springernature.com/ontologies/product-market-codes/B21007 615 0$aCancer research. 615 0$aOncology  . 615 0$aPharmacology. 615 14$aCancer Research. 615 24$aOncology. 615 24$aPharmacology/Toxicology. 676 $a616.107 702 $aPatel$b Vinood B$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aPreedy$b Victor R$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910253896303321 996 $aBiomarkers in cardiovascular disease$92076591 997 $aUNINA